Status:

UNKNOWN

The Role of the Glutamatergic System in the Extinction of Conditioned Reinforcement Processes

Lead Sponsor:

Central Institute of Mental Health, Mannheim

Collaborating Sponsors:

German Research Foundation

Conditions:

Alcohol Drinking

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

PHASE3

Brief Summary

The aim of this project is to explore whether the extinction of cue-reactivity following a cue-exposure based intervention in volunteers with an alcohol dependence is facilitated by drugs that increas...

Eligibility Criteria

Inclusion

  • current DSM-IV/ ICD-10 diagnosis of alcohol dependence
  • controlled abstinence for a period of 5 to 21 days following admission to inpatient detoxification or day-clinic care
  • women (in childbearing age): use of a highly effective method of contraception
  • normal or corrected-to-normal vision
  • ability to provide written informed consent

Exclusion

  • diagnosis of additional axis I or II disorders (according to DSM-IV( ICD- 10 criteria) either currently or within the past 12 months (except nicotine dependence)
  • positive drug screening
  • current medication with anti-convulsive or psychotropic drugs
  • MRI ineligibility
  • sensitivity to study medication as evidenced by a history of adverse drug experience
  • severe withdrawal symptoms (e.g. convulsions, delirium)
  • disposition towards experiencing convulsions/ epilepsy
  • history of schizophrenic disorders/ affective psychosis
  • neurological diseases that might affect the dopaminergic, limbic and frontal cortices or extrapyramidal motor functioning
  • major diseases (e.g. diabetes, liver cirrhosis, heart disease)
  • physical illness interfering with study procedures or affecting study outcomes
  • pregnancy (positive test results)/ lactation period
  • suicidal tendencies/ increased risk that others might be harmed -

Key Trial Info

Start Date :

March 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT00926900

Start Date

March 1 2009

Last Update

November 28 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Central Institute of Mental Health

Mannheim, Germany, 68159